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Abstract
Background: The coronary artery calcium (CAC) score is an independent predictor of coronary heart
disease. We sought to combine information from the CAC score with information from conventional
cardiac risk factors to produce post-test risk estimates, and to determine whether the score may add
clinically useful information.
Methods: We measured the independent cross-sectional associations between conventional cardiac risk
factors and the CAC score among asymptomatic persons referred for non-contrast electron beam
computed tomography. Using the resulting multivariable models and published CAC score-specific relative
risk estimates, we estimated post-test coronary heart disease risk in a number of different scenarios.
Results: Among 9341 asymptomatic study participants (age 35–88 years, 40% female), we found that
conventional coronary heart disease risk factors including age, male sex, self-reported hypertension,
diabetes and high cholesterol were independent predictors of the CAC score, and we used the resulting
multivariable models for predicting post-test risk in a variety of scenarios. Our models predicted, for
example, that a 60-year-old non-smoking non-diabetic women with hypertension and high cholesterol
would have a 47% chance of having a CAC score of zero, reducing her 10-year risk estimate from 15%
(per Framingham) to 6–9%; if her score were over 100, however (a 17% chance), her risk estimate would
be markedly higher (25–51% in 10 years). In low risk scenarios, the CAC score is very likely to be zero or
low, and unlikely to change management.
Conclusion:  Combining information from the CAC score with information from conventional risk
factors can change assessment of coronary heart disease risk to an extent that may be clinically important,
especially when the pre-test 10-year risk estimate is intermediate. The attached spreadsheet makes these
calculations easy.
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Background
Aggressive primary prevention of coronary heart disease
(CHD) is most appropriate in patients at relatively high
risk of CHD events [1,2]. The coronary artery calcium
(CAC) score is an independent predictor of coronary heart
disease risk [3-7], and therefore may help in deciding how
aggressively to pursue cholesterol-lowering, anti-platelet
therapy and other primary prevention strategies. To use a
given CAC score result, however, one must know how that
score compares with the score of an average person of the
same sex, age and CHD risk factor profile. A CAC score of
50, for example, may be unusually high for a 40-year-old
woman without other CHD risk factors, but unusually
low for a 70-year-old man with hypertension. The same
score, therefore, affects risk assessment in opposite direc-
tions for these two patients. How should a clinician use
this CAC score (or any other) when assessing the CHD
risk of a more typical patient, say a 60-year-old woman
with hypertension and high cholesterol?
To answer this question, we need to know the effects of
age, sex and other CHD risk factors on the expected distri-
bution of CAC scores. Several large cross-sectional studies
have described the prevalence and extent of CAC among
different age/sex groups [6,8-10] without accounting for
conventional CHD risk factors that may strongly influ-
ence predicted CAC scores. Five previous studies exam-
ined how CAC relates to conventional CHD risk factors
[11-15]. Only one of these was adequately powered [15],
none adequately accounted for the abnormal distribution
of CAC scores, and none yielded estimates usable for clin-
ical decision-making.
We identified a large sample of men and women without
clinical CHD who presented for electron beam computed
tomography scanning. Using questionnaire data collected
from these patients about smoking habits and medical
history (hypertension, high cholesterol and diabetes), we
determined how conventional CHD risk factors, along
with age and sex, affect CAC scores. We then developed a
method for combining information from conventional
risk factors and the CAC score (easy spreadsheet calculator
attached), and we present several examples illustrating
how that method may be applied in common clinical
situations.
Methods
Study sample
All persons referred by their physician to an electron beam
computed tomography (EBCT) scanning center in Nash-
ville, Tennessee for measurement of coronary artery calci-
fication between May 15, 1995 and December 31, 1997
were eligible for inclusion. Subjects with a history of CHD
or complaining currently of any chest pain were excluded,
as were subjects for whom CHD risk factor data were
incomplete or missing. Only the first CAC score was
included for those who received more than one EBCT
scan.
Measurement of coronary heart disease risk factors
Current age, sex and presence of CHD risk factors were
elicited by questionnaire from subjects and referring phy-
sicians. Each subject was labeled with hypertension, high
cholesterol and/or diabetes mellitus if they answered
affirmatively to the question, "Has your physician ever
told you that you needed medicine for X?", or if their phy-
sician confirmed that such a condition was documented
in their medical records. Patients were labeled as smokers
if they currently smoked or had quit smoking within the
preceding 3 months. No direct measurements of blood
pressure, lipids or glucose were taken for the purposes of
this study.
Estimation of the 10-year risk of coronary heart disease 
events
We estimated the 10-year risk of a first CHD event using
published mathematical models based on the Framing-
ham study [16]. For this purpose, we assumed that sub-
jects reporting hypertension had systolic blood pressures
of 140–160 mmHg and/or diastolic blood pressures of
90–100 mmHg (Stage I hypertension), and that subjects
without hypertension had systolic pressures of 120–130
and diastolic pressures of 80–85 mmHg. We also assumed
that patients with high cholesterol had low-density lipo-
protein (LDL) cholesterol levels of 130–159 mg/dl and
high density lipoprotein (HDL) cholesterol levels of 35–
44 mg/dl, whereas patients without high cholesterol had
LDL cholesterol levels of 100–129 mg/dl and HDL choles-
terol levels of 45–49 mg/dl (for men) or 50–59 mg/dl (for
women). Smoking and diabetes mellitus were dichoto-
mous variables in both Framingham models [16] and our
data set. We then used published model coefficients [16]
to estimate the 10-year risk for each patient in our study.
Measurement of the CAC score
Each subject underwent electron beam computed tomog-
raphy scanning with an Imatron C-100 or C-150 scanner
(Imatron, South San Francisco, California) after giving
written informed consent. During a single breath hold, 40
consecutive slices of 3 mm thickness were obtained start-
ing at the level of the carina and proceeding to the level of
the diaphragm. Scans were obtained within 100 ms and
were electrocardiographically triggered at 60–80% of the
R-R interval. Coronary calcification was defined as a
plaque of at least 3 consecutive pixels (area = 1.03 mm2)
with density ≥ 130 Hounsfield units. The CAC score was
calculated according to the method described by Agatston
[17].BMC Medicine 2004, 2:31 http://www.biomedcentral.com/1741-7015/2/31
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Statistical analysis
We categorized patients according to age and sex, and
examined histograms, quantile plots and box plots in
each category to evaluate distributional normality. The
CAC score is fundamentally not normally distributed
because of the large percentage of zero measurements,
and hence is not amenable to a normalizing transforma-
tion, as noted by others [13]. We also considered a cen-
sored normal distribution, which would have allowed a
one-step Tobit regression analysis. However, even after
square- and cube-root transformations, the zero scores
were distributed in a manner inconsistent with the Tobit
regression model. After exclusion of zero values, however,
the log-transformed CAC score was approximately nor-
mally distributed (Figure 1).
This led us naturally to a two-stage modeling approach.
We first applied logistic regression to model the probabil-
ity of a non-zero score, and then used linear regression to
model the actual CAC score, log-transformed, for the sub-
set of patients with non-zero values. Using this methodol-
ogy, we assessed the independent effects of CHD risk
factors on both the presence and extent of CAC.
We considered three sets of predictors: 1) age and sex, 2)
age, sex, hypertension, high cholesterol, smoking, and
diabetes, and 3) the Framingham 10-year CHD risk esti-
mate. We examined whether the effects of age were linear
(as opposed to J-shaped, for example) by testing a quad-
ratic term in the model containing only age and sex. We
evaluated the ability of each logistic model to discrimi-
nate subjects at high and low risk for CAC using the C-sta-
tistic, and estimated the proportion of variability in the
extent of CAC explained in each linear regression model
using the adjusted-R2 statistic.
Finally, we used coefficients, intercepts and residual vari-
ance from logistic and linear models to estimate the prob-
ability that the CAC score of an individual with known
risk factors would fall into each of four standard CAC
score categories (0, 1–100, 101–400, and >400). We esti-
mated these probabilities, using models containing the
10-year risk estimate as the only predictor, for a range of
10-year risk estimates. We also estimated these probabili-
ties, using models with all CHD risk factor predictors, for
the specific clinical scenario described in the Introduction
(a 60-year-old woman with hypertension and high cho-
lesterol) and for several other scenarios. We compared the
actual distribution of CAC scores among 58–62-year-old
women with hypertension and high cholesterol in our
sample (n = 130) with predictions from 1) our two-stage
model, 2) a one-stage model using Ln(CAC score + 1) as
a continuous outcome in a linear regression model, and
3) a one-stage model using a censored normal distribu-
tion of cube-root transformed CAC scores (a Tobit regres-
sion model). This comparison was made both graphically
and statistically, using X2 tests with 3 degrees of freedom
to compare the expected frequencies based on each model
with the observed frequencies. Lower p values, in this
case, indicate a poorer fit of the model to the observed
data. All statistical analyses were performed with Stata 7.0
(College Station, Texas).
Combining information from conventional risk factors and 
the CAC score
First, we calculated the Framingham 10-year CHD risk
estimate (and corresponding 1-year risk estimate assum-
ing an equal event rate each year) according to published
models [16]. Next, we calculated the probability, as
described above, that that individual's CAC score would
fall into each one of four standard CAC score categories
[15,18,19] (0, 1–100, 101–400, and >400). We obtained
risk factor-adjusted relative risk (RR) estimates from a
meta-analysis [7] comparing the risk of a CHD event
among persons with CAC scores of 1–100 (RR = 2.1),
101–400 (RR = 5.4) and <400 (RR = 10) to the risk in a
person with a CAC score of zero. The analysis was
repeated using more conservative estimates from the same
paper: RR = 1.7 (for CAC 1–100), RR = 3.0 (for CAC 101–
400), and RR = 4.3 (for CAC>400). The post-test CHD risk
estimates for each CAC score category were then calcu-
lated algebraically by assuming that the overall 1-year
CHD risk estimate represents an average of the 1-year risk
estimates from the four CAC score categories, weighted by
the probabilities that an individual's score would fall into
each category. A spreadsheet that automates these calcula-
tions is attached.
Results
Study population
We identified 9341 persons without chest pain or a his-
tory of CHD presenting for their first EBCT scan between
4/15/95 and 12/31/97. Our sample was mostly middle-
aged, but included persons as young as 35 years and as old
as 88 years of age. Forty percent were women. The propor-
tion with cardiac risk factors was high, though only 9%
were diabetic (Table 1). Framingham 10-year CHD risk
estimates ranged widely, mostly dependent on age, but
most were between 7% and 15%.
Coronary artery calcium score distributions
Coronary artery calcium scores ranged from 0 to 4058.
The mean score (± standard deviation) was 135 (± 377),
and the median was 4 (25th–75th percentile: 0 – 87). The
prevalence of zero scores ranged from 80% among
women younger than 50 years to 5% among men 70 years
old or older. After excluding zero scores, log-transformed
CAC scores were approximately normally distributed, and
appeared to be strongly associated with age and sex (Fig-
ure 1).BMC Medicine 2004, 2:31 http://www.biomedcentral.com/1741-7015/2/31
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Distribution of coronary artery calcium scores among men and women, on a logarithmic scale, by age Figure 1
Distribution of coronary artery calcium scores among men and women, on a logarithmic scale, by age. Catego-
ries chosen for histograms are evenly spaced on a logarithmic scale, corresponding to Ln(CAC) scores of <1, 1–2, 2–3, 3–4, 4–
5, 5–6, 6–7, 7–8, and >8. The first bar represents subjects with no detectable CAC, which corresponds to an undefined 
Ln(CAC) value. CAC – Coronary artery calcium.
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Predictors of the presence and extent of coronary artery 
calcification
Age and sex were strong predictors of the presence of CAC
in logistic regression models (Table 2). There was no evi-
dence that the effects of age were non-linear (i.e. J- or U-
shaped) (p-value = 0.32 for a quadratic age term). Con-
ventional CHD risk factors were also independent predic-
tors of the presence of CAC (p < 0.001 in all cases). The
logistic model with age, sex and all CHD risk factors pro-
duced the most accurate model (C-statistic = 0.78). The
Framingham 10-year CHD risk estimate was also a very
strong predictor of coronary artery calcification, though
the model containing the 10-year risk estimate as the only
predictor was slightly less accurate (C-statistic = 0.74).
Among patients with non-zero CAC scores, age and sex
remained strong predictors of the extent of coronary artery
calcification, as measured by the Ln(CAC score) (Table 3).
Again, the effects of age appeared to be linear (p = 0.16 for
the quadratic age term). All conventional CHD risk factors
remained statistically significant predictors of the extent
of coronary artery calcification (p < 0.001 for all predic-
tors except high cholesterol at p = 0.004). Again, the
Framingham 10-year CHD risk estimate was a very strong
predictor of the extent of calcification, though when used
alone in a model, it explained somewhat less of the vari-
ance (R2 = 0.11) than the full model (R2 = 0.17).
Coronary artery calcium distribution predictions
Using these models, we estimated the probability of meas-
uring a CAC score in each of four standard CAC score cat-
egories (0, 1–100, 101–400, and >400) using the
Framingham 10-year CHD risk estimate, a value easily cal-
culated from conventional CHD risk factors using accessi-
ble web- or handheld computer-based software. These
probabilities ranged widely based on the value of the 10-
year risk estimate, with the probability of measuring a
zero CAC score going from 75% (at a 10-year risk of 2.5%)
to 13% (at a 10-year risk of 25%) (Table 4).
Risk integration example
Using the case example presented in the Background sec-
tion, we calculated that a 60-year-old woman with Stage I
hypertension (140/90 mmHg) and high cholesterol (LDL
cholesterol = 155 mg/dl, HDL cholesterol = 40 mg/dl) will
have a 15% risk of suffering a CHD event in 10 years,
according to the Framingham equation. If this women
undergoes EBCT scanning, our models predict a 47%
chance that her CAC score will be zero, a 36% chance that
it will be between 1–100, a 12% chance that it will be
between 101–400, and a 5% chance that it will be greater
than 400. By integrating this information with previously
published relative risk estimates (see Additional File 1),
we estimate her 10-year CHD risk to be as low as 6% (if
her CAC score is 0), or as high as 51% (if her CAC score is
>400). These estimates are only moderately sensitive to
variation in the relative risk assumptions (Table 5), and
may be easily calculated in any clinical scenario in which
CHD risk factor data is available; see Table 5 for several
other examples.
Comparing predictions from different modeling strategies
Our strategy outperformed two other modeling strategies
in predicting the actual CAC distribution among the 58–
62-year-old non-smoking non-diabetic women with
hypertension and high cholesterol in our study sample (n
= 127) (Figure 2). The one-stage regression model using
Ln(CAC score +1) as the outcome, which has been uti-
lized extensively in previous research [11,12,14,20], per-
formed particularly poorly.
Discussion
In this article, we present a clinically useful method of
combining information from the CAC score with pre-test
Table 1: Characteristics of 9341 patients meeting inclusion criteria
Characteristic N (%) or mean ± SD
Age (years) 54 ± 10 years
Women 3782 (40%)
Hypertension* 4069 (44%)
High cholesterol* 5847 (63%)
Diabetes mellitus* 807 (9%)
Smoking† 3679 (39%)
Framingham 10-year risk estimate
- range 1.0% – 74%
- median, 25%–75% 11%, 7.0% – 15%
* – Per self report. Patients were asked whether they were under medical treatment for "X".
† – Current, or quit within the past six months
SD – Standard deviationBMC Medicine 2004, 2:31 http://www.biomedcentral.com/1741-7015/2/31
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coronary risk estimates. To fully appreciate the utility of
this analysis, it may be worthwhile to discuss the example
from the Background section further. According to current
guidelines, this 60-year-old woman, whose 10-year CHD
risk estimate is about 15%, should receive both aspirin
and cholesterol-lowering drug therapy, aiming for a goal
LDL cholesterol of 130 mg/dl [1,2]. After measuring her
CAC score, however, there is a good chance (64%) that
our recommendations would change. If her CAC score
were zero (47% chance), our estimate of her 10-year CHD
risk would be approximately halved (6–9%). Given this
information, we would continue to recommend a healthy
Table 2: Predictors of the presence of coronary artery calcium, in three logistic regression models
Modeling approach Model results
Predictors Odds ratio (95% CI) p-value C-statistic
Age and sex only*
- Age, per 10 years 2.83 (2.67 – 2.99) <0.001 0.76
- Male sex 3.60 (3.26 – 3.96) <0.001
All CHD risk factors*
- Age, per 10 years 2.78 (2.62 – 2.94) <0.001 0.78
- Male sex 3.67 (3.31 – 4.06) <0.001
- Hypertension 1.51 (1.37 – 1.66) <0.001
- Diabetes mellitus 1.85 (1.55 – 2.21) <0.001
- High cholesterol 1.40 (1.27 – 1.54) <0.001
- Smoking 1.71 (1.56 – 1.89) <0.001
Estimated 10-year risk of CHD†, only*
- 10-year risk, per 5% increase in the 
Framingham 10-year CHD risk estimate
1.96 (1.88 – 2.04) <0.001 0.74
* – Intercepts (on a log-odds scale) were -6.20, -6.76, and -1.44 for each model, respectively.
† – 10-year risk of CHD estimated according to Framingham equations [16]; for assumptions used, see Methods.
CHD – Coronary heart disease; CI – Confidence interval.
Table 3: Predictors of the extent of coronary artery calcium, as measured by log-transformed non-zero coronary artery calcium scores, 
in three linear regression models.
Model approach Model results
Predictors Coefficients (95% CI) Corresponding percent increase in natural 
CAC scores*
p-values Adjusted R2
Age and sex only†
- Age, per 10 years 0.68 (0.63 – 0.73) 97% (88 – 107%) <0.001 0.14
- Male sex 0.72 (0.61 – 0.82) 105% (85 – 127%) <0.001
All CHD risk factors†
- Age, per 10 years 0.69 (0.64 – 0.73) 99% (89 – 109%) <0.001 0.17
- Male sex 0.73 (0.63 – 0.83) 108% (88 – 130%) <0.001
- Hypertension 0.23 (0.14 – 0.32) 26% (14 – 38%) <0.001
- Diabetes mellitus 0.48 (0.33 – 0.62) 61% (40 – 88%) <0.001
- High cholesterol 0.15 (0.05 – 0.24) 16% (4.8 – 28%) 0.004
- Smoking 0.45 (0.35 – 0.54) 56% (42 – 71%) <0.001
Estimated 10-year risk of CHD‡, 
only†
- 10-year risk, per 5% increase 0.34 (0.31 – 0.36) 40% (36 – 44%) <0.001 0.11
* – The percent increase in the natural (non-transformed) CAC score associated with each predictor is calculated by exponentiating the regression 
coefficient from the linear regression model (when the dependent variable is log-transformed), and subtracting 1.
† – Intercepts were -0.181, -0.705, and 3.17 for each model respectively. The standard deviations of the residuals were 1.682, 1.653, and 1.707.
‡ – 10-year risk of CHD estimated according to Framingham equations [16]; for assumptions used, see Methods.
CAC – Coronary artery calcium; CI – Confidence interval; CHD – Coronary heart disease.BMC Medicine 2004, 2:31 http://www.biomedcentral.com/1741-7015/2/31
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diet and exercise, but might decide that cholesterol-lower-
ing medication is unnecessary [1], and that the benefits of
aspirin in terms of CHD prevention do not outweigh the
risk of hemorrhagic stroke associated with aspirin use [2].
On the other hand, if her CAC score were over 100 (17%
chance), our estimate of her CHD risk would be approxi-
mately doubled (25–31% if CAC score = 101–400) or tri-
pled (34–51% if CAC score > 400). In such a case, we
would certainly recommend both aspirin [2] and choles-
terol-lowering medication [1] and would probably aim
for a more aggressive LDL cholesterol goal of < 100 mg/dl
[1]. The probability that her treatment plan would be
altered by measurement of her CAC score, therefore, is
approximately 64% (the probability that her score is
either 0 or >100 = 47% + 17%), indicating likely useful-
ness of the test in this situation.
The third and fourth clinical scenarios presented in Table
5, on the other hand, provide examples where the test is
unlikely to change management. The 40-year-old woman
who smokes, for example, has a very low pre-test 10-year
CHD risk (3%). It is very likely her CAC score will be zero
(89%) or less than 100 (10%), in which case her post-test
10-year CHD risk will still be low (≤ 5%) and her manage-
ment would not change. The 80-year-old man with high
cholesterol has a high pre-test 10-year CHD risk (26%)
and a high probability of having a high CAC score (70%
will have a score > 100), in which case his post-test 10-
year CHD risk would remain over 20% and his manage-
ment would have to remain aggressive. In these cases, and
others in which the risk factor profile indicates very low or
very high pre-test risk, the test is not likely to provide use-
ful results, and the clinician might decide not to order the
test. We have provided a simple spreadsheet (see Addi-
tional File 1) that may be used by readers of this article to
replicate these analyses and apply our models to other
clinical scenarios.
While others have proposed similar Bayesian approaches
to use of the CAC score for coronary risk prediction [6,21-
24], ours has advantages. Previous approaches do gener-
ally take into account the pre-test probability of coronary
heart disease, but none consider the expected distribution
of CAC scores in the tested population after adjustment
for conventional CHD risk factors. Raggi et al advocate use
of an age- and sex-adjusted calcium score percentile, but
this ignores both persons with zero scores and the strong
effects of other risk factors such as hypertension and
hypercholesterolemia [6]. Some approaches use only sen-
sitivity and specificity from dichotomized CAC score cut-
offs [21,23], and others use CAC score-specific relative
risks generated from a single study population [6,24].
Only two provide actual post-test risk estimates for spe-
cific clinical situations [23,24]. Our approach takes into
account the pre-test coronary risk, the expected distribu-
tion of CAC scores adjusted for all conventional CHD risk
factors, and summary adjusted relative risks from a recent
meta-analysis, and provides clinically relevant post-test
risk estimates that may be directly useful to primary care
physicians, cardiologists and patients as they decide
whether or not to take medications for primary preven-
tion of CHD.
Table 4: Estimated prevalence of a coronary artery calcium score in each of four standard categories, depending on the Framingham 
estimated 10-year risk of coronary heart disease events.
Framingham 10-year CHD 
risk estimate*
Estimated prevalence of a CAC score in the given range†, %
0 1–100 101–400 >400
2.5% 75 19 4 1
5.0% 68 23 6 2
7.5% 61 28 8 3
10.0% 52 32 11 5
12.5% 44 36 13 7
15.0% 36 38 17 9
17.5% 29 40 19 12
20.0% 22 41 22 15
22.5% 17 40 25 18
25.0% 13 39 27 22
* – 10-year risk of CHD events estimated according to equations derived from the Framingham study[16]. For assumptions, see Methods.
† – Proportions of subjects in each given CAC score category were estimated by a two step process: 1) Logistic regression to predict the presence 
of CAC according to estimated 10-year risk (see Table 2 for model coefficients), and 2) Linear regression to predict the extent of CAC, as 
measured by the natural log-transformed CAC score (see Table 3 for model coefficients). Other values required for this calculation were the 
logistic regression constant (-1.44), the linear regression constant (3.17), and the standard deviation of the residuals after linear regression (1.707).
CAC – Coronary artery calcium; CHD – Coronary heart disease.BMC Medicine 2004, 2:31 http://www.biomedcentral.com/1741-7015/2/31
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This analysis confirms that conventional risk factors for
CHD (hypertension, diabetes, smoking and high choles-
terol, as well as increasing age and male sex) are inde-
pendent predictors of coronary artery calcification. This
finding is consistent with previous studies [11-15]. We
also present expected CAC score distributions for a variety
of clinical situations, which are not easily calculated from
other studies, via Tables 4 and 5 and the attached spread-
sheet calculator. Our finding that high cholesterol was less
strongly associated with the extent of CAC than other
CHD risk factors is consistent with the other large study
addressing this issue [15], and perhaps reflects effective
medical treatment for hypercholesterolemia. Male sex was
a very strong predictor of the presence and extent of CAC
– women with the same CHD risk factor profile would be
expected to develop CAC approximately 12 years later
than men, and remain approximately 11 years behind
men in the extent of their calcification.
Finally, our analysis provides a guide for how to use the
CAC score as a surrogate outcome when studying causes
of coronary artery disease (a widely used study design [25-
27]). The central problem with this approach is the funda-
mentally non-normal distribution of CAC scores, which
makes parametric statistic testing (including both simple
t-tests and multivariable linear regression) invalid. In
dealing with this issue, some researchers have used the
Ln(CAC score +1) as an outcome in linear regression anal-
yses [11,12,14,20]. This approach is not ideal, as the
Ln(CAC score +1) is still grossly non-normal – there are
too many zero scores. Adding 1 to the CAC score makes
the log-transformation possible (yielding zeroes instead
of negative infinity), but it does not solve the distribu-
tional problem, and leads to predictions that misrepresent
actual CAC score distributions (Figure 2). This
observation has led others to present only non-parametric
percentile data without multivariable modeling [6,8-10],
but this approach does not allow adjustment for
conventional CHD risk factors that we have shown are
Table 5: Examples of how to use the coronary artery calcium score to refine risk estimates.
Clinical scenario Pre-test 10-year CHD 
risk estimate*
CAC score 
category
Proportion of CAC 
scores falling within 
the given category†
Post-test 10-year risk estimate for each 
CAC score category‡
Conservative§ Optimistic§
60-year-old woman with hypertension 
and high cholesterol
15% 0: 0.47 9% 6%
1–100: 0.36 15% 13%
101–400: 0.12 25% 31%
>400: 0.05 34% 51%
50-year-old man without other CHD 
risk factors
6% 0: 0.59 4% 3%
1–100: 0.31 7% 6%
101–400: 0.07 11% 15%
>400: 0.03 16% 27%
40-year-old woman who smokes 3% 0: 0.89 2% 2%
1–100: 0.10 4% 5%
101–400: 0.01 7% 12%
>400: 0.00 10% 22%
80-year-old man with high cholesterol 26% 0: 0.05 9% 5%
1–100: 0.25 15% 10%
101–400: 0.30 26% 23%
>400: 0.40 35% 39%
* – From published Framingham equations [16].
† – These probabilities are calculated using regression equations presented in Tables 2 and 3 of this paper (full models with all predictors). See 
Methods for details.
‡ – Post-test risk estimates are calculated by assuming that the pre-test 10-year CHD risk estimate represents an average of persons with different 
CAC scores, weighted by the probability of having a CAC score in each category. The risk in each category is calculated algebraically using relative 
risk estimates§ from a recent meta-analysis [7] (see Additional File 1).
§-"Conservative" and "Optimistic" refer to assumptions made in a recent meta-analysis that attempted to quantify the value of CAC scores in 
predicting CHD events, independent of other CHD risk factors [7]. With conservative assumptions, relative risks associated with different CAC 
score categories were 1.7 (for CAC = 1–100), 3.0 (for CAC = 101–400) and 4.3 (for CAC>400) compared with a CAC score of zero. With 
optimistic assumptions, the corresponding relative risks were 2.1, 5.4, and 10.3.
CHD – Coronary heart disease; CAC score – Coronary artery calcification score.BMC Medicine 2004, 2:31 http://www.biomedcentral.com/1741-7015/2/31
Page 9 of 11
(page number not for citation purposes)
strong predictors of the CAC score. One other group used
ordinal logistic regression analysis to analyze CAC scores
categorized into four ordinal categories (quartiles in their
study sample) [13]. While such an approach does allow
multivariable modeling with ordinal logistic regression, it
does not take full advantage of the continuous nature of
the CAC score and may blur the important distinction
between zero and non-zero scores. Our analysis suggests
that a two-step approach (using first logistic regression to
model the risk of having a non-zero score, then linear
regression of log-transformed non-zero CAC scores to
model the extent of coronary calcification) will allow
multivariable analysis of the interval data provided by the
CAC score without violating the basic assumptions of par-
ametric statistics.
Our analysis has a number of limitations, perhaps the
most important being a lack of clinical detail about partic-
ipants. While we had information about conventional risk
factors (hypertension, high cholesterol, diabetes mellitus
and tobacco use), the data were only available from a
questionnaire, and were not confirmed by direct measure-
ment. Only dichotomous indicators of such conditions
were used. Furthermore, other conditions and indicators
of high CHD risk such as family history of CHD, obesity,
physical activity, income, education, and levels of C-reac-
tive protein, triglycerides and Lp(a), for example, were
unavailable. Whether such factors are important predic-
tors of the presence and extent of coronary artery calcifica-
tion is unknown. On the other hand, CHD risk
assessment is often based on the same type of limited
information we had available on each of our patients, so
the models we present are perhaps more easily applicable
to common clinical situations than models based on
more detailed clinical data. Furthermore, a historical indi-
cator of past exposure to high blood pressure or high cho-
lesterol, as we had access to in this study, may actually be
more useful as a predictor of CAC than treated blood
pressure measured at one point in time. Another impor-
tant limitation of this study is our lack of data on race/eth-
nicity – our results may not apply to all ethnic groups.
Finally, our data are limited in application to CAC scores
measured by electron beam computed tomography with 3
mm slice thickness and the described protocol. While
CAC scores measured by the latest spiral computed tom-
ography scanners appear to be similar to those generated
by electron beam computed tomography [28], we cannot
guarantee that our results apply to such scores. Our mod-
els should be applied to other similar cohorts for valida-
tion, and also applied in cohorts that include different
racial/ethnic groups and different ways of measuring the
CAC score before being used in these clinical situations.
Conclusions
The Clinical Research Roundtable at the Institute of Med-
icine has identified translation of clinical research find-
ings into improvements in medical care as the "next
scientific frontier" [29]. While our analysis has some lim-
itations, it provides methodology that will directly assist
in the translation of research into practice. Our models,
once validated, can be used directly by patients and clini-
cians to decide when it might be useful to order this
potentially expensive test, and what to do with the results.
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This spreadsheet is used for combining information from conventional risk 
factors and the coronary artery calcium score to estimate coronary heart 
disease risk in an individual patient. Step 1: Enter your patient's clinical 
information (the red numbers). Step 2: Choose an assumption about the 
coronary artery calcium score relative risks (optimistic or conservative). 
Step 3: Find the following results: 1) "Pre-test" 10-year risk of coronary 
heart disease (CHD) based on Framingham equations; 2) The probability 
of having a coronary artery calcium (CAC) score that falls within 4 stand-
ard CAC score categories; and 3) The "post-test" 10-year risk of CHD for 
each CAC score category. Step 4: Use the results to interpret a CAC score, 
or to decide whether or not to order a coronary artery calcium scan. If a 
score that would change your management is unlikely to occur, it may not 
be worth the money.
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